Webinar: Understanding the preventable burden of cancer in Canada: findings from the Canadian Population Attributable Risk of Cancer (ComPARe) study 

What is the ComPARe study?  

The ComPARe study is the most comprehensive and up-to-date study on the preventable burden of cancer in Canada. Through the ComPARe study, we know that about 4 in 10 of all cancers in Canada can be prevented through healthy living and policies that protect the health of Canadians. The ComPARe study estimates the number and percentage of cancer cases in Canada due to modifiable lifestyle, environmental and infectious agent risk factors. The study also estimates how changes to these risk factors through prevention could affect the number of cancer cases in the future.  

What will we talk about?  

In this webinar, we will provide an overview of the ComPARe study, methods, key findings and resources. The presentation will include a discussion on how these findings are being used and ideas on additional ways they can inform cancer prevention policies and programs. This session will provide you an opportunity to ask any questions about the findings of the ComPARe study and their implications directly with the investigators. 

Date: Wednesday, September 25, 2019 

Time: 12:00 PM Eastern Daylight Time 

Duration: 1 hour 

If you are unable to attend, a recording of the webinar will be made available.  

About the ComPARe study

The Canadian Population Attributable Risk of Cancer (ComPARe) study estimates the number and percentage of cancer cases in Canada caused by preventable lifestyle, environmental and infectious agent risk factors. The ComPARe study also estimates how changes to these risk factors through prevention could affect the number of cancer cases in the future.